about
Antimicrobial activity of mucosal-associated invariant T cells.Antiproliferative effects of cannabinoid agonists on deep infiltrating endometriosis.Validation over time of a nomogram including HER2 status to predict the sentinel node positivity in early breast carcinoma.The mTOR/AKT inhibitor temsirolimus prevents deep infiltrating endometriosis in mice.From prospective biobanking to precision medicine: BIO-RAIDs - an EU study protocol in cervical cancer[Breast pain: Recommendations].[3D modeling of the female pelvis by Computer-Assisted Anatomical Dissection: Applications and perspectives].First-trimester ultrasound diagnosis of skeletal dysplasia associated with increased nuchal translucency thickness.Evidence for the use of robotically assisted surgery in gynecologic cancers.Is complete cytoreductive surgery feasible in this patient with ovarian cancer?Upper outer boundaries of the axillary dissection. Result of the SENTIBRAS protocol: Multicentric protocol using axillary reverse mapping in breast cancer patients requiring axillary dissection.Time-Dependent Prognostic Impact of Circulating Tumor Cells Detection in Non-Metastatic Breast Cancer: 70-Month Analysis of the REMAGUS02 Study.Risk of port-site metastases in pelvic cancers after robotic surgery.Robot-Assisted Laparoscopic Partial Colpectomy and Intracorporeal Ileal Conduit Urinary Diversion (Bricker) for Cervical Adenocarcinoma Recurrence.Questioning patients about their adolescent history can identify markers associated with deep infiltrating endometriosis.Atypical Distant Metastasis of Breast Malignant Phyllodes Tumors: A Case Report and Literature Review.Prediction of axillary lymph node status in male breast carcinoma.Evaluation of sentinel lymph node biopsy after previous breast surgery for breast cancer: GATA study.Surgical Complexity Impact on Survival After Complete Cytoreductive Surgery for Advanced Ovarian Cancer.[Axillary management in breast cancer: The French practice versus recommendations in the post-2011 era].Tumeurs bénignes du sein : recommandations pour la pratique clinique du Collège national des gynécologues et obstétriciens français (CNGOF) – Texte courtRecommandations pour la pratique clinique : tumeurs bénignes du sein – Objectifs, méthodes et organisationSmoking habits of 411 women with histologically proven endometriosis and 567 unaffected womenPregnancy in sickle cell disease: maternal and fetal outcomes in a population receiving prophylactic partial exchange transfusionsBases anatomiques et principe du nerve-sparing au cours de l’hystérectomie radicale pour cancer du col utérinIntraoperative ultrasound localization of nonpalpable breast cancers[Management of breast nipple discharge: Recommendations]Clinical practice guidelines from the French College of Gynecologists and Obstetricians (CNGOF): benign breast tumors - short textClinico-pathology and prognosis of endometrial cancer in patients previously treated for breast cancer, with or without tamoxifen: a comparative study in 363 patientsFrom prospective clinical trial to reducing social inequalities in health: The DESSEIN trial, concept and design of a multidisciplinary study in precarious patients with breast cancerPerioperative morbidity of radical trachelectomy with lymphadenectomy in early-stage cervical cancer: a French prospective multicentric cohort
P50
Q34022899-D4FDAF42-498A-4568-B451-1E3BAF2850D0Q34358271-518755DD-992D-4D86-A9DE-FBF19AE5E4E9Q34407319-A10161F8-6D56-45EE-B1B7-A43AB0D4FB7FQ35168199-41E6DB6D-E526-4206-878C-BA6C5D9089F5Q35831356-F692AF21-C255-4F03-80D9-265A00EC8E05Q35833901-8700A86B-B09E-42ED-B418-1DF610A73D61Q35929385-4EB526C3-3B31-4F95-A464-34555F7FC139Q36854569-9ACAF5A2-4370-4250-8C57-FB3D67633339Q38902247-8B025829-B02C-4690-8513-91281AE3B423Q39449338-29E9D47A-7CBB-4D52-958E-B51E8F53CC03Q40524923-0AE72646-C933-40A5-8453-879E56377894Q41094757-4FCF6D33-1A54-4889-B5E6-3ED10F16EDEDQ41522427-1155AFDD-9BDF-40D9-AC1E-D7E03FCE767EQ43161322-0AB6E7D5-31AA-4045-A3D2-6ABC87499A24Q45269204-08B3C65F-38E9-485E-8C3C-16AF42E38C8FQ47143399-887F2EF5-BC74-4A01-8AFA-A6E3A6FACEC0Q51304719-6AE7117A-360C-43C0-AA71-12F46BFC52B9Q53096263-7E3C7218-9411-452D-B93B-6DAA1A1530C7Q53139274-64882EA3-1735-4A55-8B11-809BD62C24BAQ53144687-0FBA4343-D793-4AAD-9F29-538D8FE28F0DQ58174534-785C66E3-5841-4EFE-84FB-012273CCDB6EQ58174545-8DB9E438-5301-4FE6-83E5-12DCA1259B18Q61859488-5D147470-7238-4673-A695-CC5E46019A25Q61859490-D2781587-DAF7-49CB-9EDD-159FC997E449Q62977894-EE357310-F223-488F-81EC-72A2DBDD57B1Q80414021-4977955D-2721-4977-8275-BEC7FB809F9CQ86643541-C150A9C7-6260-4C3A-A81D-A1E74A579EC1Q87441927-922924A7-38FD-4699-9B1D-54114BFF27B0Q87491214-8E6737D8-A6A4-4C14-8D7E-4C89EBC263ACQ91101645-1A91932A-37C8-4195-BBF3-FBFF9CE8E6E4Q92469952-F6791EAB-C948-4606-A4A2-22501814D780
P50
description
hulumtuese
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Charlotte Ngo
@ast
Charlotte Ngo
@en
Charlotte Ngo
@es
Charlotte Ngo
@nl
type
label
Charlotte Ngo
@ast
Charlotte Ngo
@en
Charlotte Ngo
@es
Charlotte Ngo
@nl
prefLabel
Charlotte Ngo
@ast
Charlotte Ngo
@en
Charlotte Ngo
@es
Charlotte Ngo
@nl
P106
P21
P31
P496
0000-0002-6225-8803